New strategy aims to curb HIV by expanding addiction treatment in central asia
NCT ID NCT05579470
First seen Oct 31, 2025 · Last updated Jun 22, 2026 · Updated 28 times
Summary
This study looks at how to increase access to medication-assisted treatment for opioid addiction in Kazakhstan, Kyrgyzstan, and Tajikistan. Researchers will train local health officials and track how many people start and stay on treatment. The goal is to reduce HIV infections, which are common among people who inject drugs in this region.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Columbia University Global Health Research Center of Central Asia
RECRUITINGAlmaty, Kazakhstan
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Den Sooluk Nuru
RECRUITINGBishkek, Kyrgyzstan
Contact Email: •••••@•••••
Contact
-
Institute for International Health and Education
RECRUITINGDushanbe, Tajikistan
Contact Email: •••••@•••••
Contact
-
Yale University
ACTIVE_NOT_RECRUITINGNew Haven, Connecticut, 06510, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
NIATx (a behavioral intervention using training and coaching to improve addiction treatment services)
What this could lead to
If successful, this could provide a proven method to scale up opioid addiction treatment in Central Asia, helping to prevent HIV and other health crises in the region.
What could go wrong
This is an implementation study, not a test of a new drug or cure. Success depends on local cooperation and resources, and results may not apply to other regions.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.